150 related articles for article (PubMed ID: 31034795)
1. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation.
Liu C; Fang Y
Biochem Pharmacol; 2019 Sep; 167():58-63. PubMed ID: 31034795
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Biomolecular Condensates by Poly(ADP-ribose).
Rhine K; Odeh HM; Shorter J; Myong S
Chem Rev; 2023 Jul; 123(14):9065-9093. PubMed ID: 37115110
[TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Potential of Amyloidogenic Proteins.
Jin Y; Vadukul DM; Gialama D; Ge Y; Thrush R; White JT; Aprile FA
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923609
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein aggregation for the treatment of degenerative diseases.
Eisele YS; Monteiro C; Fearns C; Encalada SE; Wiseman RL; Powers ET; Kelly JW
Nat Rev Drug Discov; 2015 Nov; 14(11):759-80. PubMed ID: 26338154
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in Vascular/Neurological Disorders and the Road Ahead.
Alzahrani FA; Riza YM; Eid TM; Almotairi R; Scherschinski L; Contreras J; Nadeem M; Perez SE; Raikwar SP; Jha RM; Preul MC; Ducruet AF; Lawton MT; Bhatia K; Akhter N; Ahmad S
Cells; 2024 Apr; 13(8):. PubMed ID: 38667285
[TBL] [Abstract][Full Text] [Related]
6. Combating deleterious phase transitions in neurodegenerative disease.
Darling AL; Shorter J
Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118984. PubMed ID: 33549703
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of aging-related proteinopathies in Caenorhabditis elegans.
Kim DK; Kim TH; Lee SJ
Exp Mol Med; 2016 Oct; 48(10):e263. PubMed ID: 27713398
[TBL] [Abstract][Full Text] [Related]
8. Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.
Yang L; Guttman L; Dawson VL; Dawson TM
Biochem Pharmacol; 2024 Mar; ():116174. PubMed ID: 38552851
[TBL] [Abstract][Full Text] [Related]
9. Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson's disease.
Ma QW; Han RT; Wu ZJ; Zhou JJ; Chen MT; Zhang XZ; Ma WZ; Feng N
Front Pharmacol; 2024; 15():1363212. PubMed ID: 38476326
[TBL] [Abstract][Full Text] [Related]
10. Defining and predicting transdiagnostic categories of neurodegenerative disease.
Cornblath EJ; Robinson JL; Irwin DJ; Lee EB; Lee VM; Trojanowski JQ; Bassett DS
Nat Biomed Eng; 2020 Aug; 4(8):787-800. PubMed ID: 32747831
[TBL] [Abstract][Full Text] [Related]
11. The detection methods currently available for protein aggregation in neurological diseases.
Li JY; Zhou CM; Jin RL; Song JH; Yang KC; Li SL; Tan BH; Li YC
J Chem Neuroanat; 2024 Jul; 138():102420. PubMed ID: 38626816
[TBL] [Abstract][Full Text] [Related]
12. Single molecule imaging of protein aggregation in Dementia: Methods, insights and prospects.
Danial JSH; Klenerman D
Neurobiol Dis; 2021 Jun; 153():105327. PubMed ID: 33705938
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose): A Dynamic Trigger for Biomolecular Condensate Formation.
Leung AKL
Trends Cell Biol; 2020 May; 30(5):370-383. PubMed ID: 32302549
[TBL] [Abstract][Full Text] [Related]
14. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation.
Wang C; Duan Y; Duan G; Wang Q; Zhang K; Deng X; Qian B; Gu J; Ma Z; Zhang S; Guo L; Liu C; Fang Y
Mol Cell; 2020 Aug; 79(3):443-458.e7. PubMed ID: 32649883
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-Ribosylation) in Age-Related Neurological Disease.
McGurk L; Rifai OM; Bonini NM
Trends Genet; 2019 Aug; 35(8):601-613. PubMed ID: 31182245
[TBL] [Abstract][Full Text] [Related]
16. PARP-1 Activation Directs FUS to DNA Damage Sites to Form PARG-Reversible Compartments Enriched in Damaged DNA.
Singatulina AS; Hamon L; Sukhanova MV; Desforges B; Joshi V; Bouhss A; Lavrik OI; Pastré D
Cell Rep; 2019 May; 27(6):1809-1821.e5. PubMed ID: 31067465
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between protein post-translational modifications and phase separation.
Liu Y; Feng W; Wang Y; Wu B
Cell Commun Signal; 2024 Feb; 22(1):110. PubMed ID: 38347544
[TBL] [Abstract][Full Text] [Related]
18. Liquid-liquid phase separation in DNA double-strand breaks repair.
Wang YL; Zhao WW; Shi J; Wan XB; Zheng J; Fan XJ
Cell Death Dis; 2023 Nov; 14(11):746. PubMed ID: 37968256
[TBL] [Abstract][Full Text] [Related]
19. Liquid-liquid phase separation regulates alpha-synuclein aggregate and mitophagy in Parkinson's disease.
Hou K; Liu T; Li J; Xian M; Sun L; Wei J
Front Neurosci; 2023; 17():1250532. PubMed ID: 37781241
[TBL] [Abstract][Full Text] [Related]
20. (Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation.
Cordeiro Y; Freire MHO; Wiecikowski AF; do Amaral MJ
Biophys Rev; 2023 Aug; 15(4):577-589. PubMed ID: 37681103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
